版本:
中国

BRIEF-Kite Pharma says one patient in KTE-C19 study died

May 8 Kite Pharma Inc

* Kite says one patient in safety study testing cancer drug, KTE-C19, developed multiple organ failure and then fatal cerebral edema: conf call Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐